Inventurus Knowledge Solutions Ltd

Inventurus Knowl Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Inventurus Knowledge Solutions Ltd

₹ 1,676 2.33%
29 May - close price
ikshealth.com BSE: 544309 NSE: IKS
About

Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform[1]

Key Points

Business Overview:[1]
IKSL is a technology-enabled healthcare solutions provider which offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. It partners with an outpatient and inpatient health care organizations, enabling them to deliver superior clinical care through a fee for value model.

Website BSE NSE
  • Market Cap ₹ 28,764 Cr.
  • Current Price ₹ 1,676
  • High / Low ₹ 1,876 / 1,262
  • Stock P/E 50.8
  • Book Value ₹ 104
  • Dividend Yield 0.00 %
  • ROCE 44.0 %
  • ROE 37.6 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 32.4% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 37.8%

Cons

  • Stock is trading at 16.1 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Information Technology Information Technology IT - Services IT Enabled Services

Part of BSE 500 BSE Information Technology Nifty 500 Nifty Smallcap 100 BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
250 183 201 240 241 290 319 356 404 413
113 123 123 124 138 161 170 178 207 201
Operating Profit 137 60 79 116 103 129 150 178 196 212
OPM % 55% 33% 39% 48% 43% 44% 47% 50% 49% 51%
7 7 1 6 6 2 2 2 2 1
Interest 6 7 2 2 4 3 3 2 3 4
Depreciation 5 7 7 7 7 7 7 9 10 11
Profit before tax 133 53 70 113 99 121 142 168 185 198
Tax % 15% 20% 18% 18% 16% 17% 20% 18% 21% 15%
113 43 57 92 83 100 113 138 146 169
EPS in Rs 6.61 2.49 3.33 5.37 4.82 5.82 6.58 8.07 8.52 9.85
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
161 203 388 418 560 759 873 973 1,491
139 149 252 252 329 444 478 546 756
Operating Profit 22 54 136 166 231 316 394 427 735
OPM % 14% 27% 35% 40% 41% 42% 45% 44% 49%
0 0 31 16 1 -3 33 15 7
Interest 8 8 7 7 6 5 16 11 12
Depreciation 5 10 36 26 19 20 22 29 37
Profit before tax 8 36 123 148 208 288 390 402 693
Tax % 0% 0% 1% 6% 9% 12% 14% 17% 18%
8 36 122 139 189 253 337 332 567
EPS in Rs 10.51 44.55 148.09 168.19 11.04 14.83 19.72 19.35 33.00
Dividend Payout % 0% 0% 16% 14% 485% 66% 0% 0% 0%
Compounded Sales Growth
10 Years: 22%
5 Years: 29%
3 Years: 25%
TTM: 53%
Compounded Profit Growth
10 Years: 32%
5 Years: 32%
3 Years: 27%
TTM: 71%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 11%
Return on Equity
10 Years: %
5 Years: 40%
3 Years: 38%
Last Year: 38%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 8 8 8 8 17 17 17 17 17
Reserves -40 -2 221 368 501 622 811 1,210 1,771
74 79 0 62 53 43 227 77 110
58 66 141 62 133 154 101 101 265
Total Liabilities 100 151 370 500 704 836 1,156 1,405 2,164
16 32 36 72 63 49 116 101 1,502
CWIP 14 26 0 0 0 0 0 10 0
Investments 4 4 5 16 16 19 473 734 10
66 88 329 412 624 767 567 560 653
Total Assets 100 151 370 500 704 836 1,156 1,405 2,164

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
16 52 141 168 237 248 119 274 550
-21 -38 -80 -165 -81 -140 -149 -104 -600
5 -2 -36 -32 -54 -148 -186 24 -7
Net Cash Flow 0 12 25 -30 102 -40 -216 194 -57
Free Cash Flow -5 13 130 161 228 240 99 238 509
CFO/OP 75% 109% 123% 111% 118% 95% 49% 79% 93%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 130 101 35 23 25 32 83 116 97
Inventory Days
Days Payable
Cash Conversion Cycle 130 101 35 23 25 32 83 116 97
Working Capital Days -80 -38 -6 3 -55 -39 -8 93 37
ROCE % 70% 47% 46% 52% 47% 35% 44%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025
Adjusted EBITDA per employee
INR million

Log in to view insights

Please log in to see hidden values.

Login
Average Ageing of Top 10 Clients
Years
Number of Healthcare Organizations / Clients
Count
Revenue Contribution from Top 10 Customers
Percentage
Total Employees
Count
Clinically Trained Staff
Count
Revenue from Repeat Customers
Percentage
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
63.72% 63.72% 63.72% 63.72% 63.72% 63.72%
5.48% 5.38% 6.50% 7.02% 7.56% 8.19%
4.45% 4.02% 4.33% 4.89% 6.06% 6.40%
23.52% 24.29% 22.88% 21.90% 20.29% 19.39%
2.85% 2.58% 2.57% 2.46% 2.37% 2.31%
No. of Shareholders 67,58357,71459,21857,57760,78860,385

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls